文献速递肝病消化道肿瘤与早癌

果糖-1,6-二磷酸醛缩酶B缺失通过激活胰岛素受体信号和脂肪生成促进肝细胞癌发生

Fructose-1,6-Bisphosphate Aldolase B Depletion Promotes Hepatocellular Carcinogenesis Through Activating Insulin Receptor Signaling and Lipogenesis.
PubMed 文献 · Hepatology · 2021-08-26

该研究利用全局或肝脏特异性ALDOB敲除小鼠在DEN诱导的HCC模型中,结合代谢流分析和脂质组学,发现ALDOB与胰岛素受体(IR)物理互作并抑制PI3K-AKT通路及IR核转位;ALDOB缺失通过释放IR/ALDOB互作激活IR信号促进新生脂肪生成(DNL)和肿瘤发生,而恢复ALDOB或抑制p-AKT/FASN可减轻HCC。

要点

  • ALDOB与IR互作,抑制PI3K-AKT信号和IR核转位。
  • ALDOB缺失通过释放IR/ALDOB互作激活IR信号和DNL促癌。
  • 恢复ALDOB或抑制p-AKT/FASN可减轻L-ALDOB-/-小鼠HCC。

核心结论

  • ALDOB缺失主要通过释放IR/ALDOB互作激活IR信号,促进DNL和HCC,提示潜在治疗策略。

研究设计与样本

  • 使用全局或肝脏特异性ALDOB敲除(L-ALDOB-/-)小鼠在N-二乙基亚硝胺(DEN)诱导的HCC模型中研究,并通过AAV在L-ALDOB-/-小鼠中恢复ALDOB表达。
  • 采用13C6-葡萄糖进行代谢流分析追踪葡萄糖来源的新生脂肪酸合成,并进行非靶向脂质组学和靶向脂肪酸质谱分析。

主要发现

  • ALDOB与IR物理互作,通过下调PI3K-AKT通路和抑制IR核转位减弱IR信号。
  • ALDOB缺失或ALDOB突变破坏IR/ALDOB互作促进DNL和肿瘤发生,而在L-ALDOB-/-小鼠中恢复ALDOB可显著减轻。
  • ALDOB-R46A突变体(减弱IR/ALDOB互作)比ALDOB-R43A(释放ALDOB/AKT互作)表现出更显著的肿瘤发生,而敲低IR足以削弱两种突变体的促瘤效应。
  • 抑制磷酸化AKT或脂肪酸合酶可显著减轻L-ALDOB-/-小鼠的HCC。
  • 在人HCC肿瘤组织中,ALDOB下调与IR信号和DNL上调相关。

临床怎么用

  • ALDOB下调可能作为HCC中IR信号和DNL激活的生物标志物。
  • 靶向IR信号或DNL(如抑制p-AKT或FASN)可能是ALDOB缺失相关HCC的潜在治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Insulin receptor (IR) transduces cell surface signal through phosphoinositide 3-kinase (PI3K)-AKT pathways or translocates to the nucleus and binds to the promoters to regulate genes associated with insulin actions, including de novo lipogenesis (DNL). Chronic activation of IR signaling drives malignant transformation, but the underlying mechanisms remain poorly defined. Down-regulation of fructose-1,6-bisphosphate aldolase (ALDO) B in hepatocellular carcinoma (HCC) is correlated with poor prognosis. We aim to study whether and how ALDOB is involved in IR signaling in HCC. APPROACH AND RESULTS: Global or liver-specific ALDOB knockout (L-ALDOB-/- ) mice were used in N-diethylnitrosamine (DEN)-induced HCC models, whereas restoration of ALDOB expression was achieved in L-ALDOB-/- mice by adeno-associated virus (AAV). 13 C6 -glucose was employed in metabolic flux analysis to track the de novo fatty acid synthesis from glucose, and nontargeted lipidomics and targeted fatty acid analysis using mass spectrometry were performed. We found that ALDOB physically interacts with IR and attenuates IR signaling through down-regulating PI3K-AKT pathways and suppressing IR nuclear translocation. ALDOB depletion or disruption of IR/ALDOB interaction in ALDOB mutants promotes DNL and tumorigenesis, which is significantly attenuated with ALDOB restoration in L-ALDOB-/- mice. Notably, attenuated IR/ALDOB interaction in ALDOB-R46A mutant exhibits more significant tumorigenesis than releasing ALDOB/AKT interaction in ALDOB-R43A, whereas knockdown IR sufficiently diminishes tumor-promoting effects in both mutants. Furthermore, inhibiting phosphorylated AKT or fatty acid synthase significantly attenuates HCC in L-ALDOB-/- mice. Consistently, ALDOB down-regulation is correlated with up-regulation of IR signaling and DNL in human HCC tumor tissues. CONCLUSIONS: Our study reports a mechanism by which loss of ALDOB activates IR signaling primarily through releasing IR/ALDOB interaction to promote DNL and HCC, highlighting a potential therapeutic strategy in HCC.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Liu G, Wang N, Zhang C, et al. Fructose-1,6-Bisphosphate Aldolase B Depletion Promotes Hepatocellular Carcinogenesis Through Activating Insulin Receptor Signaling and Lipogenesis. Hepatology. 2021. PMID: 34292642. doi:10.1002/hep.32064

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。